BiotechTube
Acella Pharmaceuticals

Acella Pharmaceuticals

Alpharetta, United States· Est.
acellapharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $75M

Overview

Acella Pharmaceuticals is a U.S.-based, private specialty generics company founded in 2002 and headquartered in Alpharetta, Georgia. It maintains a commercial portfolio of affordable medications in therapeutic areas such as thyroid health (featuring NP Thyroid®), dermatology, women's health, and cough/cold. The company's strategy centers on a diversified product portfolio, strategic partnerships, and a commitment to quality and affordability, positioning it in the competitive generic drug market.

EndocrinologyDermatologyWomen's HealthGastrointestinalRespiratoryNutritional Supplementation

Technology Platform

Operational platform focused on quality, compliance, and strategic partnerships for generic drug development and manufacturing; no proprietary discovery technology indicated.

Funding History

1
Total raised:$75M
Debt$75M

Opportunities

The sustained demand for affordable generic medications across multiple therapeutic areas provides a stable market.
Strategic partnerships offer a capital-efficient path to portfolio expansion and accessing new scientific innovations without heavy internal R&D investment.

Risk Factors

The company faces intense price competition in the generic drug market and significant regulatory risk related to manufacturing quality and compliance.
Revenue dependence on key products like NP Thyroid® creates concentration risk.

Competitive Landscape

Acella competes in the crowded generic pharmaceuticals market against large global generics firms (e.g., Teva, Viatris) and numerous smaller specialty companies. Its differentiation is based on a focused portfolio in specific therapeutic niches, quality, and affordability.

More companies in Small Molecule Drugs →More companies in United States →